Article
About molecular profile of lung cancer in Tunisian patients.
Journal of immunoassay & immunochemistry - 1 Jan 2018
Mezni Faouzi, Mlika Mona, Boussen Hamouda, Ghedira Habib, Fenniche Soraya, Faten Talmoudi, Loriot Marie-Anne
Abstract excerpt
BACKGROUND: Molecular profile of lung cancer is well known in developed countries. These countries reached the era of liquid biopsies, immunotherapy, and urine circulating tumor DNA. The discrepancies between developed countries and developing ones are becoming deeper. Because of a lack of data in Tunisia, we tried to analyze the molecular profile of non-small-cell carcinomas and to assess the morphologic subtype...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
